Changes to PBS antibiotic prescribing

0
In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

Oral PDE4 inhibitors in the management of stable COPD

0
Almost 1.45 million Australians have some form of chronic obstructive pulmonary disease (COPD). This equates to one in seven Australians over 40 suffering from...

Can I eat where I compound?

0
Compounding environments must be designed to minimise contamination risk —  including keeping meal breaks well away from the bench.

TGA approves Pfizer booster for teens

0
Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Assessing and managing sore throat

0
Sore throat is a symptom rather than a diagnosis. Although usually mild it can be painful and warrants careful investigation by pharmacists.

Fluoxetine: can it decrease weight in obese and overweight patients?

0
This evidence summary presents the best available evidence on the effectiveness of fluoxetine in decreasing weight.